Hepatitis E Diagnostic Tests Market Trends

  • Report ID: 6507
  • Published Date: Oct 03, 2024
  • Report Format: PDF, PPT

Hepatitis E Diagnostic Tests Market Trends

Growth drivers

  • Surging incidents of Hepatitis E: Poor sanitation and contaminated water together with increased global travel have been contributing factors to the increasing incidence of hepatitis E. This viral infection is transmitted mainly via the fecal-oral route and is particularly prevalent in areas with substandard water management. An increase in hepatitis E has also led to a growth in the demand for more sensitive diagnostic equipment. The key growth factors include the advancement of molecular diagnostic technology, public health efforts in early detection, and a better understanding of the prevention and treatment of hepatitis E. Such factors are vital in fighting and controlling the spread of the virus worldwide.
  • Innovative diagnostic technologies: The hepatitis E diagnostic tests market has witnessed tremendous growth due to advances and innovation in technologies for enhancing detection with improved sensitivity. Recent improvements include the integration of molecular techniques such as PCR that enable rapid detection of HEV RNA in clinical samples. Serological assays, using new ELISA platforms, further increase sensitivity and specificity in the detection of anti-HEV antibodies, thus facilitating earlier diagnosis and epidemiologic research and fueling market growth. These factors collectively contribute toward more effective surveillance and management of hepatitis E as part of addressing public health challenges emanating from the disease and driving the growth of the hepatitis E diagnostic tests market.
  • Increasing awareness: Improved awareness of hepatitis E and wide-ranging screening programs are the main factors in managing the virus. Rising public health campaigns to educate populations of causes and ways in which the disease may be prevented have boosted the demand for early diagnosis testing. Combining such efforts with government initiatives to screen high-risk regions has greatly increased the use of hepatitis E diagnostic. Other growth drivers include advancements in diagnostic technologies, such as PCR-based tests that help increase accuracy and speed in detecting the virus during its acute phase.

Challenges

  • Lack of standardized diagnostic tools: The lack of standardized diagnostic tools for hepatitis E, indeed, represents an important challenge in the accurate diagnosis of the disease. To date, there is no globally accepted test, and it is based on considerable variability in the sensitivity, specificity, and overall performance of available diagnostic assays, which makes it somewhat impractical for interlaboratory or international comparison. This variability, of course, will naturally make cross-regional study of etiology, surveillance, or management of the respective disease challenging. Standardized testing protocols are necessary to ensure reliable and comparable diagnostic outcomes worldwide.
  • Cost of advanced diagnostic: The major challenge in the universal application of hepatitis E diagnosis is the cost of the advanced diagnostic tools: PCR and genotyping assays, which consume significantly high resource inputs. These molecular tests are sensitive and specific but require expensive equipment, reagents, and personnel. This diagnostic workup is expensive, making it inaccessible; therefore, early diagnosis and management of hepatitis E remain impossible in most vulnerable populations. Further access to low-cost diagnostic technologies can help advance public health outcomes.

Hepatitis E Diagnostic Tests Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

4.5%

Base Year Market Size (2024)

USD 62.9 million

Forecast Year Market Size (2037)

USD 106.6 million

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

 

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 6507
  • Published Date: Oct 03, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In 2024, the industry size of the hepatitis E diagnostic tests market was over USD 62.9 million.

The market size of the hepatitis E diagnostic tests landscape is projected to surpass USD 106.6 million by the end of 2037 expanding at a CAGR of 4.5% during the forecast period i.e., between 2025-2037.

The major players in the market are Fortress Diagnostic, Genscript Biotech Corporation, Guangzhou Wondfo Biotech Co., Ltd., Medsource Ozone Biomedicals Pvt. Ltd., MIKROGEN GmbH, MP Biomedicals, and others.

In terms of test type, the ELISA HEV IgM segment is anticipated to garner the largest market share of 51.5% by 2037 and display significant growth opportunities during 2025-2037.

The market in North America is projected to hold the largest revenue share of 44.6% by the end of 2037 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample